1st projects have been selected in PRISMAP-The European medical isotope programme.
Plenary presentation on new developments exploiting isotope mass separation in nuclear medicine presented at the 1st AccConf'22 at IAEA.
MEDICIS restarts its program today. Mass separation will be applied to purify and separate Sm-153 from a target produced at BR2. Some details on the project here.
World cancer day: webinar at 11:30 on MEDICIS mass separation and its impact on theranostics here.
The 1st call for user projects of PRISMAP is launched! More information here.
PRISMAP-The European medical radionuclides programme sets out to substantially change the European landscape for novel and emerging medical radionuclides. More information here.
A KNOWLEDGE TRANSFER SUCCESS STORY
Read more ...
GRANTS & DONATIONS - CERN & Society Foundation
The CERN KT-Fund
La Fondation pour l'innovation sur le cancer et la biologie
The ADAM company
PRISMAP and EURAMED in H2020